Standard

Heart rate response to beta blockers (atenolol add-on therapy)

MARCHF1 · rs17044565

What each result means

C/C Published research associates this genotype with typical/baseline likelihood of Heart rate response to beta blockers (atenolol add-on therapy) — no copies of the reported risk allele.
C/T Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with Heart rate response to beta blockers (atenolol add-on therapy).
T/T Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Heart rate response to beta blockers (atenolol add-on therapy) compared to the general population.
Source

Questions about rs17044565

What is rs17044565?

rs17044565 is a single position in the genome, in or near the MARCHF1 gene. Published research associates it with heart rate response to beta blockers (atenolol add-on therapy). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs17044565 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs17044565 come from?

GWAS Catalog, J Am Heart Assoc 2018, PMID:29478026. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

← See all variants